nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Anagrelide—Depression—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Anagrelide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Anagrelide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Anagrelide—Discomfort—Triamcinolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Anagrelide—Discomfort—Methylprednisolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Anagrelide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Anagrelide—Renal failure—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Anagrelide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Anagrelide—Confusional state—Methylprednisolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Anagrelide—Malaise—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Anagrelide—Malaise—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Anagrelide—Oedema—Triamcinolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Anagrelide—Syncope—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Anagrelide—Syncope—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Anagrelide—Arrhythmia—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Anagrelide—Infection—Triamcinolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Anagrelide—Sweating—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Anagrelide—Infection—Methylprednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Anagrelide—Haematuria—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Anagrelide—Shock—Triamcinolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Anagrelide—Insomnia—Prednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Anagrelide—Alopecia—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Anagrelide—Shock—Methylprednisolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Anagrelide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Anagrelide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Anagrelide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Anagrelide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Anagrelide—Epistaxis—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Anagrelide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Anagrelide—Tachycardia—Triamcinolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Anagrelide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Anagrelide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Anagrelide—Malnutrition—Prednisone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Anagrelide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Anagrelide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Anagrelide—Convulsion—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Anagrelide—Convulsion—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Anagrelide—Hypertension—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Anagrelide—Hypertension—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Anagrelide—Myalgia—Betamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Anagrelide—Myalgia—Dexamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Anagrelide—Discomfort—Dexamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Anagrelide—Discomfort—Betamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Anagrelide—Haemoglobin—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Anagrelide—Hypotension—Methylprednisolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Anagrelide—Pain—Prednisolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Anagrelide—Haemorrhage—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Anagrelide—Hepatitis—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Anagrelide—Pharyngitis—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Anagrelide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Anagrelide—Vision blurred—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Anagrelide—Urethral disorder—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Anagrelide—Oedema—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Anagrelide—Oedema—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Anagrelide—Insomnia—Triamcinolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Anagrelide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Anagrelide—Infection—Betamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Anagrelide—Infection—Dexamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Anagrelide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Anagrelide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Anagrelide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Anagrelide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Anagrelide—Visual impairment—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Anagrelide—Anaemia—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Anagrelide—Shock—Dexamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Anagrelide—Shock—Betamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Anagrelide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Anagrelide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Anagrelide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Anagrelide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Anagrelide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Anagrelide—Tachycardia—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Anagrelide—Tachycardia—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Anagrelide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Anagrelide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Anagrelide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Anagrelide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Anagrelide—Malaise—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Anagrelide—Eye disorder—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Anagrelide—Syncope—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Anagrelide—Tinnitus—Methotrexate—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Anagrelide—Anorexia—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Anagrelide—Anorexia—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Anagrelide—Urticaria—Prednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Anagrelide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Anagrelide—Fatigue—Triamcinolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Anagrelide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Anagrelide—Pain—Triamcinolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Anagrelide—Loss of consciousness—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Anagrelide—Hypotension—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Anagrelide—Hypotension—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Anagrelide—Convulsion—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Anagrelide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Anagrelide—Hypertension—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Anagrelide—Chills—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Anagrelide—Myalgia—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Anagrelide—Arthralgia—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Anagrelide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Anagrelide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Anagrelide—Alopecia—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Anagrelide—Insomnia—Dexamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Anagrelide—Insomnia—Betamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Anagrelide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Anagrelide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Anagrelide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Anagrelide—Discomfort—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Anagrelide—Malnutrition—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Anagrelide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Anagrelide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Anagrelide—Urticaria—Triamcinolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Anagrelide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Anagrelide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Anagrelide—Oedema—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Anagrelide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Anagrelide—Decreased appetite—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Anagrelide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Anagrelide—Infection—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Anagrelide—Back pain—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Anagrelide—Fatigue—Dexamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Anagrelide—Fatigue—Betamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Anagrelide—Shock—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Anagrelide—Pain—Betamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Anagrelide—Pain—Dexamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Anagrelide—Nervous system disorder—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Anagrelide—Tachycardia—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Anagrelide—Skin disorder—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Anagrelide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Anagrelide—Vision blurred—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Anagrelide—Anorexia—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Anagrelide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Anagrelide—Anaemia—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Anagrelide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Anagrelide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Anagrelide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Anagrelide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Anagrelide—Malaise—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Anagrelide—Urticaria—Betamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Anagrelide—Urticaria—Dexamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Anagrelide—Dizziness—Prednisolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Anagrelide—Asthenia—Triamcinolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Anagrelide—Abdominal pain—Betamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Anagrelide—Body temperature increased—Betamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Anagrelide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Anagrelide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Anagrelide—Asthenia—Methylprednisolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Anagrelide—Insomnia—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Anagrelide—Paraesthesia—Prednisone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Anagrelide—Pruritus—Triamcinolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Anagrelide—Cough—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Anagrelide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Anagrelide—Convulsion—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Anagrelide—Dyspepsia—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Anagrelide—Arthralgia—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Anagrelide—Myalgia—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Anagrelide—Chest pain—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Anagrelide—Decreased appetite—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Anagrelide—Rash—Prednisolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Anagrelide—Dermatitis—Prednisolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Anagrelide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Anagrelide—Fatigue—Prednisone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Anagrelide—Headache—Prednisolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Anagrelide—Discomfort—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Anagrelide—Constipation—Prednisone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Anagrelide—Confusional state—Methotrexate—psoriatic arthritis	0.000985	0.000985	CcSEcCtD
Anagrelide—Dizziness—Triamcinolone—psoriatic arthritis	0.000979	0.000979	CcSEcCtD
Anagrelide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000976	0.000976	CcSEcCtD
Anagrelide—Infection—Methotrexate—psoriatic arthritis	0.000971	0.000971	CcSEcCtD
Anagrelide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000964	0.000964	CcSEcCtD
Anagrelide—Asthenia—Dexamethasone—psoriatic arthritis	0.000963	0.000963	CcSEcCtD
Anagrelide—Asthenia—Betamethasone—psoriatic arthritis	0.000963	0.000963	CcSEcCtD
Anagrelide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000958	0.000958	CcSEcCtD
Anagrelide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000957	0.000957	CcSEcCtD
Anagrelide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000956	0.000956	CcSEcCtD
Anagrelide—Nausea—Prednisolone—psoriatic arthritis	0.000956	0.000956	CcSEcCtD
Anagrelide—Pruritus—Betamethasone—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Anagrelide—Pruritus—Dexamethasone—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Anagrelide—Skin disorder—Methotrexate—psoriatic arthritis	0.000949	0.000949	CcSEcCtD
Anagrelide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000945	0.000945	CcSEcCtD
Anagrelide—Vomiting—Triamcinolone—psoriatic arthritis	0.000941	0.000941	CcSEcCtD
Anagrelide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000939	0.000939	CcSEcCtD
Anagrelide—Rash—Triamcinolone—psoriatic arthritis	0.000933	0.000933	CcSEcCtD
Anagrelide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000932	0.000932	CcSEcCtD
Anagrelide—Anorexia—Methotrexate—psoriatic arthritis	0.000932	0.000932	CcSEcCtD
Anagrelide—Rash—Methylprednisolone—psoriatic arthritis	0.000931	0.000931	CcSEcCtD
Anagrelide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00093	0.00093	CcSEcCtD
Anagrelide—Urticaria—Prednisone—psoriatic arthritis	0.000929	0.000929	CcSEcCtD
Anagrelide—Headache—Triamcinolone—psoriatic arthritis	0.000927	0.000927	CcSEcCtD
Anagrelide—Headache—Methylprednisolone—psoriatic arthritis	0.000925	0.000925	CcSEcCtD
Anagrelide—Abdominal pain—Prednisone—psoriatic arthritis	0.000924	0.000924	CcSEcCtD
Anagrelide—Body temperature increased—Prednisone—psoriatic arthritis	0.000924	0.000924	CcSEcCtD
Anagrelide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000919	0.000919	CcSEcCtD
Anagrelide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000919	0.000919	CcSEcCtD
Anagrelide—Hypotension—Methotrexate—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00089	0.00089	CcSEcCtD
Anagrelide—Dizziness—Betamethasone—psoriatic arthritis	0.000888	0.000888	CcSEcCtD
Anagrelide—Dizziness—Dexamethasone—psoriatic arthritis	0.000888	0.000888	CcSEcCtD
Anagrelide—Insomnia—Methotrexate—psoriatic arthritis	0.000884	0.000884	CcSEcCtD
Anagrelide—Nausea—Triamcinolone—psoriatic arthritis	0.000879	0.000879	CcSEcCtD
Anagrelide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000878	0.000878	CcSEcCtD
Anagrelide—Nausea—Methylprednisolone—psoriatic arthritis	0.000877	0.000877	CcSEcCtD
Anagrelide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000871	0.000871	CcSEcCtD
Anagrelide—Somnolence—Methotrexate—psoriatic arthritis	0.000869	0.000869	CcSEcCtD
Anagrelide—Dyspepsia—Methotrexate—psoriatic arthritis	0.00086	0.00086	CcSEcCtD
Anagrelide—Vomiting—Dexamethasone—psoriatic arthritis	0.000854	0.000854	CcSEcCtD
Anagrelide—Vomiting—Betamethasone—psoriatic arthritis	0.000854	0.000854	CcSEcCtD
Anagrelide—Decreased appetite—Methotrexate—psoriatic arthritis	0.00085	0.00085	CcSEcCtD
Anagrelide—Rash—Betamethasone—psoriatic arthritis	0.000847	0.000847	CcSEcCtD
Anagrelide—Rash—Dexamethasone—psoriatic arthritis	0.000847	0.000847	CcSEcCtD
Anagrelide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000846	0.000846	CcSEcCtD
Anagrelide—Dermatitis—Betamethasone—psoriatic arthritis	0.000846	0.000846	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000844	0.000844	CcSEcCtD
Anagrelide—Fatigue—Methotrexate—psoriatic arthritis	0.000843	0.000843	CcSEcCtD
Anagrelide—Headache—Betamethasone—psoriatic arthritis	0.000841	0.000841	CcSEcCtD
Anagrelide—Headache—Dexamethasone—psoriatic arthritis	0.000841	0.000841	CcSEcCtD
Anagrelide—Asthenia—Prednisone—psoriatic arthritis	0.000839	0.000839	CcSEcCtD
Anagrelide—Pain—Methotrexate—psoriatic arthritis	0.000836	0.000836	CcSEcCtD
Anagrelide—Pruritus—Prednisone—psoriatic arthritis	0.000827	0.000827	CcSEcCtD
Anagrelide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000805	0.000805	CcSEcCtD
Anagrelide—Diarrhoea—Prednisone—psoriatic arthritis	0.0008	0.0008	CcSEcCtD
Anagrelide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000799	0.000799	CcSEcCtD
Anagrelide—Nausea—Dexamethasone—psoriatic arthritis	0.000798	0.000798	CcSEcCtD
Anagrelide—Nausea—Betamethasone—psoriatic arthritis	0.000798	0.000798	CcSEcCtD
Anagrelide—Urticaria—Methotrexate—psoriatic arthritis	0.000776	0.000776	CcSEcCtD
Anagrelide—Dizziness—Prednisone—psoriatic arthritis	0.000773	0.000773	CcSEcCtD
Anagrelide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000773	0.000773	CcSEcCtD
Anagrelide—Body temperature increased—Methotrexate—psoriatic arthritis	0.000773	0.000773	CcSEcCtD
Anagrelide—Vomiting—Prednisone—psoriatic arthritis	0.000743	0.000743	CcSEcCtD
Anagrelide—Rash—Prednisone—psoriatic arthritis	0.000737	0.000737	CcSEcCtD
Anagrelide—Dermatitis—Prednisone—psoriatic arthritis	0.000737	0.000737	CcSEcCtD
Anagrelide—Headache—Prednisone—psoriatic arthritis	0.000733	0.000733	CcSEcCtD
Anagrelide—Asthenia—Methotrexate—psoriatic arthritis	0.000701	0.000701	CcSEcCtD
Anagrelide—Nausea—Prednisone—psoriatic arthritis	0.000695	0.000695	CcSEcCtD
Anagrelide—Pruritus—Methotrexate—psoriatic arthritis	0.000691	0.000691	CcSEcCtD
Anagrelide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000669	0.000669	CcSEcCtD
Anagrelide—Dizziness—Methotrexate—psoriatic arthritis	0.000646	0.000646	CcSEcCtD
Anagrelide—Vomiting—Methotrexate—psoriatic arthritis	0.000621	0.000621	CcSEcCtD
Anagrelide—Rash—Methotrexate—psoriatic arthritis	0.000616	0.000616	CcSEcCtD
Anagrelide—Dermatitis—Methotrexate—psoriatic arthritis	0.000616	0.000616	CcSEcCtD
Anagrelide—Headache—Methotrexate—psoriatic arthritis	0.000612	0.000612	CcSEcCtD
Anagrelide—Nausea—Methotrexate—psoriatic arthritis	0.00058	0.00058	CcSEcCtD
